For: |
Wierzbicki PM, Adrych K, Kartanowicz D, Stanislawowski M, Kowalczyk A, Godlewski J, Skwierz-Bogdanska I, Celinski K, Gach T, Kulig J, Korybalski B, Kmiec Z. Underexpression of |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i27/4363.htm |
Number | Citing Articles |
1 |
Piotr M. Wierzbicki, Jakub Klacz, Agnieszka Rybarczyk, Tomasz Slebioda, Marcin Stanislawowski, Agata Wronska, Anna Kowalczyk, Marcin Matuszewski, Zbigniew Kmiec. Identification of a suitable qPCR reference gene in metastatic clear cell renal cell carcinoma. Tumor Biology 2014; 35(12): 12473 doi: 10.1007/s13277-014-2566-9
|
2 |
Jinyun Li, Chongchang Zhou, Shumin Ni, Shaomin Wang, Chao Ni, Ping Yang, Meng Ye. Methylatedclaudin-11associated with metastasis and poor survival of colorectal cancer. Oncotarget 2017; 8(56): 96249 doi: 10.18632/oncotarget.21997
|
3 |
Tomasz Jerzy Ślebioda, Marcin Stanisławowski, Marta Cyman, Piotr Mieczysław Wierzbicki, Dorota Żurawa-Janicka, Jarek Kobiela, Wojciech Makarewicz, Marek Guzek, Zbigniew Kmieć. Distinct Expression Patterns of Two Tumor Necrosis Factor Superfamily Member 15 Gene Isoforms in Human Colon Cancer. Digestive Diseases and Sciences 2019; 64(7): 1857 doi: 10.1007/s10620-019-05507-8
|
4 |
Bing Xu, Duoxiang Sun, Zhihua Wang, Haiyan Weng, Dabao Wu, Xuefen Zhang, Ying Zhou, Weiping Hu. Expression of LATS family proteins in ovarian tumors and its significance. Human Pathology 2015; 46(6): 858 doi: 10.1016/j.humpath.2015.02.012
|
5 |
Ahmad A.D. Sharif, Alexander Hergovich. The NDR/LATS protein kinases in immunology and cancer biology. Seminars in Cancer Biology 2018; 48: 104 doi: 10.1016/j.semcancer.2017.04.010
|
6 |
Jihong Deng, Wen Zhang, Shuangyue Liu, Hongmei An, Lu Tan, Lisha Ma. LATS1 suppresses proliferation and invasion of cervical cancer. Molecular Medicine Reports 2017; 15(4): 1654 doi: 10.3892/mmr.2017.6180
|
7 |
Magdalena Szarynska, Agata Olejniczak, Piotr Wierzbicki, Jaroslaw Kobiela, Dariusz Laski, Zbigniew Sledzinski, Krystian Adrych, Marek Guzek, Zbigniew Kmiec. FasR and FasL in colorectal cancer. International Journal of Oncology 2017; 51(3): 975 doi: 10.3892/ijo.2017.4083
|
8 |
Yu Wang, Li-Hua Huang, Can-Xia Xu, Jing Xiao, Li Zhou, Dan Cao, Xiao-Min Liu, Yong Qi. <italic>Connexin 32</italic> and <italic>43</italic> promoter methylation in <italic>Helicobacter pylori</italic>-associated gastric tumorigenesis. World Journal of Gastroenterology 2014; 20(33): 11770-11779 doi: 10.3748/wjg.v20.i33.11770
|
9 |
Kimberly C. Lin, Hyun Woo Park, Kun-Liang Guan. Deregulation and Therapeutic Potential of the Hippo Pathway in Cancer. Annual Review of Cancer Biology 2018; 2(1): 59 doi: 10.1146/annurev-cancerbio-030617-050202
|
10 |
Hongling Li, Dezhuan Da, Wenqiang Yu, Lu Chen, Shuai Yang, Baolong Zhang, Yongying Wang, Linyu Li, Chunyan Dang. Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLC. Human Molecular Genetics 2023; 32(1): 79 doi: 10.1093/hmg/ddac185
|
11 |
KE-HONG CHEN, JIANG HE, DE-LIN WANG, JIAN-JIA CAO, MEI-CAI LI, XIU-MIN ZHAO, XIA SHENG, WEN-BIN LI, WU-JIANG LIU. Methylation-associated inactivation of LATS1 and its effect on demethylation or overexpression on YAP and cell biological function in human renal cell carcinoma. International Journal of Oncology 2014; 45(6): 2511 doi: 10.3892/ijo.2014.2687
|
12 |
Mohammad Ayoub Rigi Ladiz, Maryam Najafi, Dor Mohammad Kordi-Tamandani. Contribution of LATS1 and LATS2 promoter methylation in OSCC development. Journal of Cell Communication and Signaling 2017; 11(1): 49 doi: 10.1007/s12079-016-0356-4
|
13 |
Hypermethylated LATS2 gene with decreased expression in female breast cancer: A case control study from North India. Gene 2018; 676: 156 doi: 10.1016/j.gene.2018.07.033
|
14 |
Marc Riffet, Yassine Eid, Maxime Faisant, Audrey Fohlen, Benjamin Menahem, Arnaud Alves, Fatéméh Dubois, Guénaelle Levallet, Céline Bazille. Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers. Cancers 2021; 13(23): 5957 doi: 10.3390/cancers13235957
|
15 |
Jianping Zou, Ling Zhou, Yi Le, Zhi Fang, Min Zhong, Fengting Nie, Xianpin Wei, Xiaomei Zhang, Zhen Chen, Lingling Cai, Heng Wang, Jianping Xiong, Ziling Fang, Xiaojun Xiang. WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein. Cell Communication and Signaling 2023; 21(1) doi: 10.1186/s12964-023-01050-2
|
16 |
Daniel A Barron, Jacob D Kagey. The role of the Hippo pathway in human disease and tumorigenesis. Clinical and Translational Medicine 2014; 3(1) doi: 10.1186/2001-1326-3-25
|
17 |
Maryam Najafi, Dor Mohammad Kordi-Tamandani, Mohammad Arish. Evaluation ofLATS1andLATS2Promoter Methylation with the Risk of Pterygium Formation. Journal of Ophthalmology 2016; 2016: 1 doi: 10.1155/2016/5431021
|
18 |
Yu-Han Hu, Qing Chen, Yan-Xia Lu, Jian-Ming Zhang, Chun Lin, Fan Zhang, Wen-Juan Zhang, Xiao-Min Li, Wei Zhang, Xue-Nong Li. Hypermethylation of NDN promotes cell proliferation by activating the Wnt signaling pathway in colorectal cancer. Oncotarget 2017; 8(28): 46191 doi: 10.18632/oncotarget.17580
|
19 |
Steven W. Plouffe, Zhipeng Meng, Kimberly C. Lin, Brian Lin, Audrey W. Hong, Justin V. Chun, Kun-Liang Guan. Characterization of Hippo Pathway Components by Gene Inactivation. Molecular Cell 2016; 64(5): 993 doi: 10.1016/j.molcel.2016.10.034
|
20 |
Shivani Singh, Saurav Panicker, Satish Ramalingam. Cancer Genes. 2023; : 159 doi: 10.2174/9789815080292123010009
|
21 |
Liang Xu, Peixue Li, Xue Hao, Yi Lu, Mingxian Liu, Wenqian Song, Lin Shan, Jiao Yu, Hongyu Ding, Shishuang Chen, Ailing Yang, Yi Arial Zeng, Lei Zhang, Hai Jiang. SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling. Protein & Cell 2021; 12(3): 174 doi: 10.1007/s13238-020-00742-6
|
22 |
Mona K. Saadeldin, Heba Shawer, Ahmed Mostafa, Neemat M. Kassem, Asma Amleh, Rania Siam. New genetic variants of LATS1 detected in urinary bladder and colon cancer. Frontiers in Genetics 2015; 5 doi: 10.3389/fgene.2014.00425
|
23 |
Wei Song, Jingjing Zhang, Jianbo Zhang, Miaomiao Sun, Qingxin Xia. Overexpression of lncRNA PIK3CD-AS1 promotes expression of LATS1 by competitive binding with microRNA-566 to inhibit the growth, invasion and metastasis of hepatocellular carcinoma cells. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0857-3
|
24 |
Ankita Sharma, Rafeeq Mir, Sanjeev Galande. Epigenetic Regulation of the Wnt/β-Catenin Signaling Pathway in Cancer. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.681053
|
25 |
Rumi Shin, Seongdae Lee, Kyung-Su Han, Dae Kyung Sohn, Sang Hui Moon, Dong Hyun Choi, Bong-Hyeon Kye, Hae-Jung Son, Sun Il Lee, Sumin Si, Won-Kyung Kang. Guidelines for accreditation of endoscopy units: quality measures from the Korean Society of Coloproctology. Annals of Surgical Treatment and Research 2021; 100(3): 154 doi: 10.4174/astr.2021.100.3.154
|
26 |
Wei Kang, Alfred SL Cheng, Jun Yu, Ka Fai To. Emerging role of Hippo pathway in gastric and other gastrointestinal cancers. World Journal of Gastroenterology 2016; 22(3): 1279-1288 doi: 10.3748/wjg.v22.i3.1279
|
27 |
Yiu To Yeung, Angelica Guerrero-Castilla, Mercedes Cano, Mario F. Muñoz, Antonio Ayala, Sandro Argüelles. Dysregulation of the Hippo pathway signaling in aging and cancer. Pharmacological Research 2019; 143: 151 doi: 10.1016/j.phrs.2019.03.018
|
28 |
Showkat A. Malik, Mosin S. Khan, Majeed Dar, Mahboob Ul Hussain, Mohammad A. Shah, Sheikh M. Shafi, Syed Mudassar. Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma. Pathology & Oncology Research 2018; 24(2): 207 doi: 10.1007/s12253-017-0225-3
|
29 |
Yi Pan, Joanna Hung Man Tong, Raymond Wai Ming Lung, Wei Kang, Johnny Sheung Him Kwan, Wing Po Chak, Ka Yee Tin, Lau Ying Chung, Feng Wu, Simon Siu Man Ng, Tony Wing Chung Mak, Jun Yu, Kwok Wai Lo, Anthony Wing Hung Chan, Ka Fai To. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer. Molecular Cancer 2018; 17(1) doi: 10.1186/s12943-018-0853-6
|
30 |
Steven W. Plouffe, Audrey W. Hong, Kun-Liang Guan. Disease implications of the Hippo/YAP pathway. Trends in Molecular Medicine 2015; 21(4): 212 doi: 10.1016/j.molmed.2015.01.003
|
31 |
Yi Wang, Minhao Chen. Decreased expression of LATS1 correlates with astrogliosis after spinal cord injury. Biochemical and Biophysical Research Communications 2018; 505(1): 151 doi: 10.1016/j.bbrc.2018.09.025
|
32 |
J.M. WIERZBICKA, A. BINEK, T. AHRENDS, J.D. NOWAC KA, A. SZYDŁOWSKA, Ł. TURCZYK, T. WĄSIEWICZ, P.M. WIERZBICKI, R. SĄDEJ, R.C. TUCKEY, A.T. SLOMINSKI, J. CHYBICKI, K. ADRYCH, Z. KMIEĆ, M.A. ŻMIJEWSKI. Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture. International Journal of Oncology 2015; 47(3): 1084 doi: 10.3892/ijo.2015.3088
|
33 |
Fa-Xing Yu, Zhipeng Meng, Steven W. Plouffe, Kun-Liang Guan. Hippo Pathway Regulation of Gastrointestinal Tissues. Annual Review of Physiology 2015; 77(1): 201 doi: 10.1146/annurev-physiol-021014-071733
|
34 |
Ji-Eun Oh, Takashi Ohta, Kaishi Satomi, Matthieu Foll, Geoffroy Durand, James McKay, Florence Le Calvez-Kelm, Michel Mittelbronn, Benjamin Brokinkel, Werner Paulus, Hiroko Ohgaki. Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas. Journal of Neuropathology & Experimental Neurology 2015; 74(10): 952 doi: 10.1097/NEN.0000000000000238
|
35 |
Pinelopi Nterma, Eleni Panopoulou, Eleni Papadaki-Petrou, Martha Assimakopoulou. Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal Intestine. Pathology & Oncology Research 2020; 26(1): 567 doi: 10.1007/s12253-018-00575-z
|
36 |
Chanchao Lorthongpanich, Nittaya Jiamvoraphong, Kantpitchar Supraditaporn, Phatchanat Klaihmon, Yaowalak U-pratya, Surapol Issaragrisil. The Hippo pathway regulates human megakaryocytic differentiation. Thrombosis and Haemostasis 2017; 117(01): 116 doi: 10.1160/TH16-07-0564
|
37 |
Noa Furth, Yael Aylon. The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway. Cell Death & Differentiation 2017; 24(9): 1488 doi: 10.1038/cdd.2017.99
|
38 |
Zhihao Zhang, Xianyi Zhou, Jiulin Li, Qinghui Meng, Peng Zheng. LncRNA HOTAIR promotes the migration and invasion of cervical cancer through DNMT3B/LATS1/ YAP1 pS127 axis. Reproductive Biology 2024; 24(2): 100893 doi: 10.1016/j.repbio.2024.100893
|
39 |
Xu Shen, Xiaohan Sun, Bing Sun, Tao Li, Guoliang Wu, Yuantao Li, Lai Chen, Qingxin Liu, Meng Cui, Zizhang Zhou. ARRDC3 suppresses colorectal cancer progression through destabilizing the oncoprotein YAP. FEBS Letters 2018; 592(4): 599 doi: 10.1002/1873-3468.12986
|
40 |
T.J. Grant, K. Hua, A. Singh. Molecular and Cellular Changes in the Cancer Cell. Progress in Molecular Biology and Translational Science 2016; 144: 241 doi: 10.1016/bs.pmbts.2016.09.008
|
41 |
Agnieszka Rybarczyk, Jakub Klacz, Agata Wronska, Marcin Matuszewski, Zbigniew Kmiec, Piotr M. Wierzbicki. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome. Oncology Reports 2017; 38(1): 427 doi: 10.3892/or.2017.5642
|
42 |
Feng An, Yidong Liu, Yan Hu. miR-21 inhibition of LATS1 promotes proliferation and metastasis of renal cancer cells and tumor stem cell phenotype. Oncology Letters 2017; 14(4): 4684 doi: 10.3892/ol.2017.6746
|
43 |
Yurika Matsui, Yifan Zhang, Robert F. Paulson, Zhi-Chun Lai. Dual Role of a C-Terminally Truncated Isoform of Large Tumor Suppressor Kinase 1 in the Regulation of Hippo Signaling and Tissue Growth. DNA and Cell Biology 2019; 38(1): 91 doi: 10.1089/dna.2018.4340
|